Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV

(2014) Yantao Duan et al.   Molecular Cancer

Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma

(2014) Ye Song et al.   Molecular Cancer

Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis

(2014) Lupeng Li et al.   Molecular Cancer

Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia

(2013) A.R. Matos et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma

(2013) Fengming Gong et al.   Molecular Cancer

THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling

(2011) Susann Förster et al.   MODERN PATHOLOGY

Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination

(2011) Cheng-Gang Jiang et al.   Molecular Cancer

CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo

(2010) Manuel Koch et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer

(2010) Toshihiro Nakao et al.   International Journal of Clinical Oncology

Thrombospondins function as regulators of angiogenesis

(2009) Paul Bornstein   Journal of Cell Communication and Signaling

Thrombospondin-2 Modulates Extracellular Matrix Remodeling during Physiological Angiogenesis

(2008) Marie M. Krady et al.   AMERICAN JOURNAL OF PATHOLOGY